From The Industry Experts

  1. From CRO Management To Networked Governance: The New Quality Imperative 5/20/2026

    The clinical research industry once emphasized transactional vendor management, but now it requires broader governance to enable the level of quality that enables scalability and success.

  2. Building Trust Through Connection: EmVenio At The Atlanta Black Expo 5/19/2026

    Engaging with communities in familiar settings helps raise awareness, address concerns, and create a more inclusive foundation for clinical research participation built on dialogue, respect, and long‑term relationships.

  3. Rethinking Trial Access Through Trust-Driven Design And Local Collaboration 5/19/2026

    Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

  4. Delivering Complex Oncology Trials At Scale 5/19/2026

    Parexel delivered two complex, global Phase III prostate cancer trials by aligning site selection, logistics, imaging workflows, and RAM regulatory expertise—achieving faster enrollment and on‑time execution.

  5. Will FDA's One-Day Inspection Pilot Stand The Test Of Time? 5/19/2026

    FDA's complementary pilot could help weed through a persistent examination backlog, but uncertainty and upheaval in leadership at the top puts its future in question.

  6. QA Transitions Don't Create Inspection Risk — They Reveal It 5/19/2026

    Consultant Wijdan Suliman, MD, MHA, explains how QA leadership changes can reveal risks, including differences in the interpretation, lost historical context, and more.

  7. 2026 Life Sciences Trends 5/15/2026

    Life sciences leaders in 2026 need more than breakthrough science. Build operational clarity, scalable systems, and investor-ready visibility to support growth, funding, and execution.

  8. Price Matters - Why Dash Believes In Transparency 5/15/2026

    Opaque pricing slows decisions and erodes trust. Transparency clarifies cost drivers, improves budgeting, enables confident sourcing, and strengthens long-term R&D partnerships.

  9. Optimizing Wearable Adherence In A Phase 3 Oncology Trial 5/15/2026

    Long-term wearable monitoring only works if patients keep wearing the device, and in oncology trials, that’s easier said than done.

  10. Contracting For AI In Clinical Trials: Cybersecurity, Monitoring, And Risk Allocation (Part 3) 5/15/2026

    Leibowitz Law shares the third installment of its three-part series on contracting for AI in clinical trial operations. Part 3 picks up with cybersecurity, monitoring and validation, and risk allocation.